Abstract Objective To investigate the changes of pulmonary function and fractional exhaled nitric oxide (FeNO) in the standardized treatment of bronchial asthma in children. Methods A total of 254 children who were newly diagnosed with acute exacerbation of bronchial asthma were selected as asthma group, and they were divided into two subgroups:asthma with concurrent rhinitis and asthma without concurrent rhinitis. All patients received the standardized management and treatment for one year. The pulmonary function parameters included forced expiratory volume in one second (FEV1), peak expiratory flow (PEF), maximal mid-expiratory flow (MMEF), and mid-expiratory flow at 25%, 50%, and 75% of vital capacity (MEF25, MEF50, and MEF75). The FeNO levels were measured before treatment and at 3, 6, 9, and 12 months after treatment. Another 62 healthy children were selected as the control group, and the pulmonary function and FeNO levels were measured only once. Results During one year of standardized treatment, FEV1, PEF, MMEF, MEF25, MEF50, and MEF75 gradually increased, and FeNO levels gradually decreased (P < 0.05). Indicators of large airway function, such as FEV1 and PEF, almost returned to normal after 6 months of treatment; indicators of small airway function, such as MMEF, MEF25, MEF50, and MEF75 almost returned to normal after 9 months of treatment; there were no significant differences in the above indices between the asthma group and the control group after one year of treatment (P > 0.05). However, the asthma group had a significantly higher FeNO levels than the control group after one year of treatment (P < 0.05). The asthmatic patients with concurrent rhinitis had significantly higher FeNO levels than those without concurrent rhinitis before treatment and 3 months after treatment (P < 0.05). Before treatment, there was a significant negative correlation between FeNO levels and pulmonary function parameters (P < 0.05). Conclusions With the standardized treatment of bronchial asthma in children, pulmonary function parameters gradually increase and FeNO levels gradually decrease. The recovery of large airway function occurs earlier than the recovery of small airway function. Furthermore, the effect of rhinitis on airway responsiveness should be noted.
ZHANG Hui-Qin,ZHANG Jing-Jing,LIU Yu-Dong et al. Application of pulmonary function and fractional exhaled nitric oxide tests in the standardized management of bronchial asthma in children[J]. CJCP, 2017, 19(4): 419-424.
ZHANG Hui-Qin,ZHANG Jing-Jing,LIU Yu-Dong et al. Application of pulmonary function and fractional exhaled nitric oxide tests in the standardized management of bronchial asthma in children[J]. CJCP, 2017, 19(4): 419-424.
Global Initiative for Asthma. Global strategy for asthma management and prevention[DB/OL].[2015-6-11].
[5]
American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxideand nasal nitric oxide[J]. Am J Respir Crit Care Med, 2005, 171(8):912-930.
[6]
Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline:interpretation of exhaled nitric oxide levels (FENO) for clinical applications[J]. Am J Respir Crit Care Med, 2011, 184(5):602-615.
[7]
Krouse JH, Brown RW, Fineman SM, et al. Asthma and the unified airway[J]. Otolaryngol Head Neck Surg, 2007, 136(5 Suppl):S75-106.
van den Toorn LM, Overbeek SE, de Jongste JC, et al. Airway inflammation is present during clinical remission of atopic asthma[J]. Am J Respir Crit Care Med, 2001, 164(11):2107-2113.
[10]
Goldberg S, Springer C, Avital A, et al. Can peak expiratory flow measurements estimate small airway function in asthmatic children[J]. Chest, 2001, 120(2):482-488.
[11]
Ferguson AC. Persisting airway obstruction in asymptomatic children with asthma with normal peak expiratory flow rates[J]. J Allergy Clin Immunol, 1988, 82(1):19-22.
[12]
Rao DR, Gaffin JM, Baxi SN, et al. The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity[J]. J Asthma, 2012, 49(6):586-592.
[13]
Bjermr L. The role of small airway disease in asthma[J]. Curr Opin Pulm Med, 2014, 20(1):23-30.
[14]
Pedrosa M, Cancelliere N, Barranco P, et al. Usefulness of exhaled nitric oxide for diagnosing asthma[J]. J Asthma, 2010, 47(7):817-821.
[15]
Hanson JR, De Lurgio SA, Williams DD, et al. Office-based exhaled nitric oxide measurement in children 4 years of age and older[J]. Ann Allergy Asthma Immunol, 2013, 111(5):358-363.
Hahn YS. Measurements of fractional exhaled nitric oxide in pediatric asthma[J]. Korean J Pediatr, 2013, 56(10):424-430.
[18]
Price D, Ryan D, Burden A, et al. Using fractional exhaled nitric oxide (FeNO) to diagnose steroidresponsive disease and guide asthma management in routine care[J]. Clin Transl Allergy, 2013, 3(1):37.
